HIGHLIGHTS
- who: GALNT and collaborators from the Department of Obstetrics and Gynecology, Jiading Branch of General, Jiao Tong University School General, Jiao Tong University School of Medicine, China have published the Article: O-Glycosylating Enzyme GALNT2 Predicts Worse Prognosis in Cervical Cancer, in the Journal: (JOURNAL)
- what: The authors focus on the expression pattern of mucin glycosylating enzyme GALNT2 in cervical cancer. In current study, the authors demonstrated that GALNT2 and several other GalNAc-T subfamily members (GALNT3, GALNT4, GALNT10, GALNT13 and GALNT15) were associated with worse survival rate of cervical cancer patients, and GALNT2 also . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.